Crossmark

Application of machine learning to large in vitro databases to identify drug–cancer cell interactions: azithromycin and KLK6 mutation status

Published Online: 2021-05-05

Published Print: 2021-05-27

Authors

Sherman, Jeff https://orcid.org/0000-0003-1377-0357
Verstandig, Grant

Rowe, John W. https://orcid.org/0000-0002-3620-6612
Brumer, Yisroel https://orcid.org/0000-0002-7046-0198
License Information

Text and Data Mining valid from 2021-05-05

Version of Record valid from 2021-05-05
More Information

Article History

Received: 17 February 2021

Revised: 16 March 2021

Accepted: 20 April 2021

First Online: 5 May 2021

Compliance with ethical standards

:

: JS, GV, and YB have roles at Red Cell Partners and Zephyr AI that involve the application of AI to cancer drug discovery. The authors all report no known financial interest in azithromycin.

Document is current